O
Orthox
Biotech & Life Sciences · Milton, United Kingdom · Founded 2008
Developes tissue regenerative implants which enable patients to return to a fully active, pain-free lifestyle MoreLess
Orthox is a pioneering company in the life sciences sector, focusing on innovative solutions for knee injuries. The company operates in the medical technology market, specifically targeting patients with cartilage and meniscus injuries in the knee. These injuries can lead to severe disability and often result in the need for total knee replacement, a costly and invasive procedure. Orthox aims to provide a less invasive alternative through its lead product, Cartilage, a natural implant designed to restore knee function and promote the body's own healing processes.
Orthox primarily serves patients who are at risk of or are already experiencing knee joint deterioration. This includes both young and older individuals who suffer from knee injuries that could lead to osteoarthritis. The company's products are particularly beneficial for those who want to avoid the limitations and risks associated with total knee replacement surgery.
The business model of Orthox revolves around the development, clinical testing, and eventual commercialization of its knee cartilage repair products. The company has secured significant funding from various prestigious sources, including the EU Horizon 2020 programme and the NIHR i4i programme. These funds are being used to advance the clinical strategy and bring their innovative solutions to market.
Orthox generates revenue through the sale of its medical implants once they pass clinical trials and receive regulatory approval. The company also benefits from grants and awards that support its research and development activities. By focusing on a niche but growing market, Orthox aims to address a critical medical need and reduce the number of total knee replacement surgeries performed annually.
In summary, Orthox is a forward-thinking company dedicated to improving knee health through natural, resilient implants that restore function and promote healing. Their innovative approach and strong financial backing position them well in the competitive medical technology market.
Keywords: Orthox, knee injuries, cartilage repair, medical implants, life sciences, osteoarthritis, clinical trials, EU Horizon 2020, NIHR i4i, healthcare innovation.
Company overview
Orthox company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2008
- Headquarters
- Milton, United Kingdom
- Employees
- 9
- Open positions
- None listed
- Dealroom signal
- 58.9
Valuation & funding
Orthox funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2022 | $13M | $50M | Oxford Technology · Additio Investment Group · Parkwalk Advisors | ↗ |
| SERIES A✓Equity / VC | Feb 2022 | $4.2M | $17M | Parkwalk Advisors · Oxford Technology · Perivoli Innovations · Additio Investment Group | ↗ |
| SUPPORT PROGRAM✓Other financing | Nov 2020 | $550K | — | EIT Health | — |
| GRANTOther financing | Jul 2020 | $2.8M | — | Undisclosed | — |
| GRANTOther financing | Feb 2020 | $437K | — | Undisclosed | — |
| GRANT✓Other financing | Oct 2019 | European Innovation Council | — | ||
| GRANT✓Other financing | Jan 2019 | Undisclosed | — | ||
| GRANT✓Other financing | Dec 2018 | European Innovation Council | — | ||
| EARLY VCEquity / VC | Aug 2018 | AtmosClear Investments | — | ||
| SERIES AEquity / VC | Apr 2016 | Parkwalk Advisors | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | EBITDA | Margin | Profit | Margin |
|---|---|---|---|---|
| 2026 | −$384K | — | −$1.3M | — |
| 2025 | −$384K | — | −$1.3M | — |
| 2024 | −$384K | — | −$1.3M | — |
| 2023 | −$384K | — | ||
| 2022 | −$384K | — | ||
| 2021 | −$384K | — | ||
| 2020 | −$384K | — |
Growth signals
Orthox website traffic
Latest recorded traffic for Orthox is 3.3K monthly website visits, up 153.8% over the last three months. Orthox's team grew 0% over the past year.
Comparisons
Orthox compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Orthox's talent
Source: Dealroom Talent Intelligence.
Investors
11 investors on Orthox's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Orthox has talent and traffic
team presence
In the news
Latest news about Orthox
Recent press, funding announcements, and product moves mentioning Orthox — open to read from the original sources.
Market sentiment
What the market is saying about Orthox
An AI-synthesized read of the highest-engagement posts about Orthox on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Orthox’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.